SRH Wald-Klinikum Gera

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

Gϋnter von Minckwitz, Andreas Schneeweiß, Sibylle Loibl et al. · The Lancet Oncology · 2014 · 1K citations

Gbg 66, Breast Oncology, Medicine +7

Sarcoma classification by DNA methylation profiling

Christian Koelsche, Daniel Schrimpf, Damian Stichel et al. · Nature Communications · 2021 · 512 citations · Full text

Transluminal endoscopic necrosectomy after acute pancreatitis: a multicentre study with long-term follow-up (the GEPARD Study)

H Seifert, Michael Biermer, W Schmitt et al. · Gut · 2009 · 479 citations · Full text

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial

D. Jocham, Lothar Hoffmann, Klaus Iwig et al. · The Lancet · 2004 · 432 citations

Urology, Surgical Oncology, Renal-cell Carcinoma +10

Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial

Michael R. Migden, Alexander Guminski, Ralf Gutzmer et al. · The Lancet Oncology · 2015 · 419 citations

Surgical Oncology, Medicine, Metronomic Therapy +6